| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer
1 company
Biller Scott is a Chief Scientific Officer at AGIOS PHARMACEUTICALS, INC.. Recent SEC Form 4 filings include 0 buys and 14 sells.
Estimated insider holdings value: $1.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2017 | AGIO Agios Pharmaceuticals, Inc. | Chief Scientific Officer | Sale+OE | 2,146 | $61.99 | $133,030.54 | -25.5% | |
| Aug 2, 2017 | AGIO Agios Pharmaceuticals, Inc. | Chief Scientific Officer | Sale+OE | 23,146 | $59.60 | $1,379,397.30 | -42.2% | |
| Jul 7, 2017 | AGIO Agios Pharmaceuticals, Inc. | Chief Scientific Officer | Sale+OE | 2,146 | $55.00 | $118,030.00 | -25.5% | |
| Jun 21, 2017 | AGIO Agios Pharmaceuticals, Inc. | Chief Scientific Officer | Sale+OE | 4,292 | $55.00 | $236,060.00 | -94.2% | |
| Apr 3, 2017 | AGIO Agios Pharmaceuticals, Inc. | Chief Scientific Officer | Sale+OE | 2,146 | $58.03 | $124,532.38 | -12.0% | |
| Mar 20, 2017 | AGIO Agios Pharmaceuticals, Inc. | Chief Scientific Officer | Sale+OE | 6,438 | $55.00 | $354,090.00 | -17.2% | |
| Nov 14, 2016 | AGIO Agios Pharmaceuticals, Inc. | Chief Scientific Officer | Sale+OE | 32,500 | $65.00 | $2,112,500.00 | -37.5% | |
| Nov 10, 2016 | AGIO Agios Pharmaceuticals, Inc. | Chief Scientific Officer | Sell | 5,000 | $60.00 | $300,000.00 | -17.2% | |
| Oct 5, 2016 | AGIO Agios Pharmaceuticals, Inc. | Chief Scientific Officer | Sell | 5,000 | $55.00 | $275,000.00 | -23.8% | |
| Sep 20, 2016 | AGIO Agios Pharmaceuticals, Inc. | Chief Scientific Officer | Sell | 5,000 | $50.00 | $250,000.00 | -19.2% |